Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

307 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Criteria for discharge of patients with Ebola virus diseases in high-income countries.
Bevilacqua N, Nicastri E, Chinello P, Puro V, Petrosillo N, Di Caro A, Capobianchi MR, Lanini S, Vairo F, Pletschette M, Zumla A, Ippolito G; INMI Ebola Team. Bevilacqua N, et al. Among authors: puro v. Lancet Glob Health. 2015 Dec;3(12):e739-40. doi: 10.1016/S2214-109X(15)00205-3. Lancet Glob Health. 2015. PMID: 26608193 Free article. No abstract available.
Detection of Mycobacterium tuberculosis DNA in CD34+ peripheral blood mononuclear cells of adults with tuberculosis infection and disease.
Repele F, Alonzi T, Navarra A, Farroni C, Salmi A, Cuzzi G, Delogu G, Gualano G, Puro V, De Carli G, Girardi E, Palmieri F, Martineau AR, Goletti D. Repele F, et al. Among authors: puro v. Int J Infect Dis. 2024 Apr;141S:106999. doi: 10.1016/j.ijid.2024.106999. Epub 2024 Mar 7. Int J Infect Dis. 2024. PMID: 38458427 Free article.
Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine.
Picchianti-Diamanti A, Navarra A, Aiello A, Laganà B, Cuzzi G, Salmi A, Vanini V, Maggi F, Meschi S, Matusali G, Notari S, Agrati C, Salemi S, Di Rosa R, Passarini D, Di Gioia V, Sesti G, Conti F, Spinelli FR, Corpolongo A, Chimenti MS, Ferraioli M, Sebastiani GD, Benucci M, Li Gobbi F, Santoro AP, Capri A, Puro V, Nicastri E, Goletti D. Picchianti-Diamanti A, et al. Among authors: puro v. Vaccines (Basel). 2023 Nov 2;11(11):1684. doi: 10.3390/vaccines11111684. Vaccines (Basel). 2023. PMID: 38006015 Free PMC article.
Association between sex hormones and anti-S/RBD antibody responses to COVID-19 vaccines in healthcare workers.
Anticoli S, Dorrucci M, Iessi E, Chiarotti F, Di Prinzio RR, Vinci MR, Zaffina S, Puro V, Colavita F, Mizzoni K, Meschi S, Vonesch N, Albano C, Ortona E, Ruggieri A, Tomao P. Anticoli S, et al. Among authors: puro v. Hum Vaccin Immunother. 2023 Dec 15;19(3):2273697. doi: 10.1080/21645515.2023.2273697. Epub 2023 Nov 14. Hum Vaccin Immunother. 2023. PMID: 37961893 Free PMC article.
Evaluation of Cross-Immunity to the Mpox Virus Due to Historic Smallpox Vaccination.
Matusali G, Petruccioli E, Cimini E, Colavita F, Bettini A, Tartaglia E, Sbarra S, Meschi S, Lapa D, Francalancia M, Bordi L, Mazzotta V, Coen S, Mizzoni K, Beccacece A, Nicastri E, Pierelli L, Antinori A, Girardi E, Vaia F, Sette A, Grifoni A, Goletti D, Puro V, Maggi F. Matusali G, et al. Among authors: puro v. Vaccines (Basel). 2023 Sep 28;11(10):1541. doi: 10.3390/vaccines11101541. Vaccines (Basel). 2023. PMID: 37896943 Free PMC article.
Dynamic Evolution of Humoral and T-Cell Specific Immune Response to COVID-19 mRNA Vaccine in Patients with Multiple Sclerosis Followed until the Booster Dose.
Ruggieri S, Aiello A, Tortorella C, Navarra A, Vanini V, Meschi S, Lapa D, Haggiag S, Prosperini L, Cuzzi G, Salmi A, Quartuccio ME, Altera AMG, Garbuglia AR, Ascoli Bartoli T, Galgani S, Notari S, Agrati C, Puro V, Nicastri E, Gasperini C, Goletti D. Ruggieri S, et al. Among authors: puro v. Int J Mol Sci. 2023 May 10;24(10):8525. doi: 10.3390/ijms24108525. Int J Mol Sci. 2023. PMID: 37239872 Free PMC article.
307 results